+421.6%
MRNA vs PLTD
-77.5%
+499.2%
-53.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | PLTD | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +2.2% | -5.6% | -2.8% |
| 7D | -12.1% | -4.8% | -7.4% | -13.2% |
| 30D | -1.3% | +16.9% | -18.1% | +4.2% |
| 3M | +250.9% | +2.6% | +248.3% | +260.1% |
| 6M | +343.0% | -36.2% | +379.3% | +317.9% |
| YTD | +657.4% | -19.4% | +676.9% | +662.5% |
| 1Y | +794.9% | -22.5% | +817.4% | +797.9% |
| All | +421.6% | -77.5% | +499.2% | +319.2% |
Cumulative growth
Daily Returns
Daily percentage return beside PLTD.
Daily Out/Under-Performance
Portfolio return minus PLTD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PLTD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded PLTD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling